Cancer Research | Penn Today

The actual chip of human leukemia bone marrow where chambers and channels were filled with food dyes.

‘Leukemia-on-a-chip’ could transform CAR T blood cancer treatments

In a collaborative effort with NYU, Penn researchers have helped pioneer a novel 3D platform that mimics the human bone marrow and immune environment, enabling more predictive testing of cancer immunotherapy success in patients, including CAR T cell therapies.

3 min. read

Food insecurity linked to elevated mortality risk among cancer survivors

A new study from the Perelman School of Medicine shows that cancer survivors experiencing food insecurity had a 28 percent relative increase in risk of death versus those who were food secure.

1 min. read

Philadelphia’s largest cancer centers unite to reduce disparities in prevention and treatment outcomes

A collaborative coalition led by researchers at the Perelman School of Medicine’s Abramson Cancer Center is improving cancer care communication and coordination in Philadelphia by leveraging new community partnerships.

A cutting-edge cancer therapy offers hope for patients with lupus

Discussing CAR T-cell therapy, Carl June of the Perelman School of Medicine asks, “The big question is: How long does it last? Are they cured?”

Penn researchers believe new potential gene therapy for glioblastoma brain cancer offers ‘a lot of hope’

Donald O’Rourke of the Perelman School of Medicine and colleagues have found that a dual-target CAR T cell therapy approach shows promise for slowing tumor growth in glioblastoma, an aggressive and fast-growing brain cancer.

Celebrity breast cancer announcements highlight rising rates in young women

Oluwadamilola Fayanju of the Perelman School of Medicine recommends that young women with breast cancer symptoms go to a center that’s experienced in breast imaging.

From no hope to a potential cure for a deadly blood cancer

Carl June of the Perelman School of Medicine discusses multiple myeloma.

Trials aim to make cancer relapse a thing of the past

At Penn Medicine, clinical trials are testing methods that may stop cancer from recurring.

6 min. read

Evidence of CAR T-cell therapy against cancers presented at U.S. conference

A study by researchers at Penn finds that that CAR T-cell therapy “shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain cancer.”

The human brain as though it is being scanned.

Dual-target CAR T-cell therapy slows growth of aggressive brain cancer

Researchers from Penn Medicine have demonstrated encouraging tumor reductions rarely seen in recurrent glioblastoma following phase I clinical trials.